Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...
As an oncologist with more than 25 years of experience across clinical care, research, drug and device development, and ...
Businesses are finding that AI is a great leveller. Organisations with mature digital infrastructures can use AI to unlock ...
Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...
Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...
Hard on the heels of a £1 billion investment package by pharma companies in last week's UK Budget, AbbVie has pledged another ...
The BioInnovation Institute (BII) has expanded a network striving to develop treatments for cardiometabolic diseases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results